SPOTLIGHT: Biotech sector poised for growth


Investment analysts say that Israel's biotech industry should see a significant hike in the amount of VC funds invested in the country. Any downturn triggered by the ongoing uproar in global financial circles isn't likely to arrive for at least two quarters. Report

Suggested Articles

The vehicle, which Blackstone claims is the largest life sciences private fund, has committed close to $1 billion to companies including Alnylam.

Since Takeda bought out Shire, it’s lost a number of high-ranking research execs from the Irish rare disease biotech; it’s also losing one of its own.

Just a few months after a series B-plus worth $75 million, U.S.-China biotech Harbour BioMed has nabbed a major $102.8 million series C.